Aducanumab for Alzheimer's disease: The never‐ending story that nurses should know
Saved in:
Main Authors: | Joel Petch (Author), Daniel Bressington (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloid
by: Lin Lin, et al.
Published: (2022) -
The Never-Ending Story of Complicated Hypertension
by: Weiss Emma, et al.
Published: (2022) -
Aducanumab and lecanemab - two novel antibodies against pathologic species of amyloid beta in the treatment of Alzheimer's disease
by: Jakub Wojcieszak
Published: (2023) -
Doping in Sports, a Never-Ending Story ?
by: Robert Alexandru Vlad, et al.
Published: (2018) -
Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease
by: Kumar Kandadi Muralidharan, et al.
Published: (2022)